The Inflammatory Bowel Disease—Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek Version

Background: The Inflammatory Bowel Disease-Disk (IBD-Disk) is a physician-administered tool that evaluates the functional status of patients with Inflammatory Bowel Disease (IBD). The aim of our study was to validate the content of the IBD-Disk in a Greek cohort of IBD patients. Methods: Two questionnaires [the IBD Disk and the IBD-Disability Index (IBD-DI)] were translated into Greek and administered to IBD patients at baseline visit, after 4 weeks and 6 months. Validation of the IBD Disk included measuring of concurrent validity, reproducibility, and internal consistency. Results: A total of 300 patients were included at baseline and 269 at follow-up. There was a good correlation between the total scores of the IBD-Disk and IBD-DI at baseline (Pearson correlation 0.87, p < 0.001). Reproducibility of the total IBD-Disk score was very good [intra-class correlation coefficient (ICC), 95% confidence interval (CI) 0.89 (0.86–0.91)]. Cronbach’s coefficient alpha for all items achieved 0.90 (95%CI 0.88–0.92), demonstrating a very good homogeneity of the IBD-Disk items. Female gender and extraintestinal manifestations were significantly associated with a higher IBD-Disk total score. Conclusions: The Greek version of the IBD-Disk proved to be a reliable and valid tool in detecting and assessing IBD-related disability in a Greek cohort of IBD patients.

[1]  J. Soares,et al.  Validation of the IBD-Disk in a Portuguese cohort , 2021, European journal of gastroenterology & hepatology.

[2]  A. Amiot,et al.  Determinants of IBD‐related disability: a cross‐sectional survey from the GETAID , 2021, Alimentary pharmacology & therapeutics.

[3]  C. Le Berre,et al.  VALIDation of the IBD-Disk instrument for assessing disability in Inflammatory Bowel Diseases in a French cohort: the VALIDate study. , 2020, Journal of Crohn's & colitis.

[4]  S. Shah,et al.  Sex-based differences in inflammatory bowel diseases: a review , 2020, Therapeutic advances in gastroenterology.

[5]  S. Vavricka,et al.  Gender Differences in Inflammatory Bowel Disease , 2020, Digestion.

[6]  E. Savarino,et al.  Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients , 2019, Gastroenterology research and practice.

[7]  J. Colombel,et al.  Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio‐economic factors , 2019, Alimentary pharmacology & therapeutics.

[8]  J. Burisch,et al.  Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study , 2018, European journal of gastroenterology & hepatology.

[9]  L. B. Mokkink,et al.  COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study , 2018, Quality of Life Research.

[10]  L M Bouter,et al.  COSMIN guideline for systematic reviews of patient-reported outcome measures , 2018, Quality of Life Research.

[11]  Alexander N. Levy,et al.  Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta‐analysis of Population‐based Studies , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  L. Peyrin-Biroulet,et al.  Systematic review and meta‐analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index , 2018, Alimentary pharmacology & therapeutics.

[13]  H. Vet,et al.  COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures , 2017, Quality of Life Research.

[14]  L. Peyrin-Biroulet,et al.  Preventing disability in inflammatory bowel disease , 2017, Therapeutic advances in gastroenterology.

[15]  Harminder Singh,et al.  Association Between IBD Disability and Reduced Work Productivity (Presenteeism): A Population-Based Study in Manitoba, Canada. , 2017, Inflammatory bowel diseases.

[16]  J. Cha,et al.  Disability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of Life , 2017, Gut and liver.

[17]  D. Franchimont,et al.  Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases , 2017, Inflammatory bowel diseases.

[18]  S. Hawthorne hospital , 2016, The Medical journal of Australia.

[19]  A. Duhamel,et al.  Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort , 2015, Gut.

[20]  O. Bolarinwa Principles and methods of validity and reliability testing of questionnaires used in social and health science researches , 2015, The Nigerian postgraduate medical journal.

[21]  K. Malone,et al.  Body Image Dissatisfaction: Clinical Features, and Psychosocial Disability in Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[22]  J. Tabibian,et al.  Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors. , 2013, Journal of Crohn's & colitis.

[23]  E. Cabré,et al.  Sexual function and patients' perceptions in inflammatory bowel disease: a case–control survey , 2013, Journal of Gastroenterology.

[24]  Eija Paavilainen,et al.  The burden of inflammatory bowel disease on health care utilization and quality of life , 2013, Scandinavian journal of gastroenterology.

[25]  J. Ellenberg,et al.  Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis , 2008, Inflammatory bowel diseases.

[26]  Marshall Godwin,et al.  Health measurement scales , 1991 .

[27]  R. F. Harvey,et al.  A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY , 1980, The Lancet.

[28]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[29]  A. Cieza,et al.  Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health , 2022 .

[30]  A. Cieza,et al.  Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health , 2022 .